Prostacyclin and atherosclerosis--experimental and clinical approaches.
Gryglewski
R J
RJ
Department of Pharmacology, Copernicus Academy of Medicine, Cracow, Poland.
Kostka-Trabka
E
E
Demińska-Kieć
A
A
Korbut
R
R
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D001685:Biological Factors / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism; D004041:Dietary Fats / Q000008:administration & dosage; D011464:Epoprostenol / Q000502:physiology* / Q000627:therapeutic use; D066298:In Vitro Techniques; D015227:Lipid Peroxidation; D008297:Male; D009569:Nitric Oxide; D011817:Rabbits
D001685:Biological Factors; D004041:Dietary Fats; D009569:Nitric Oxide; D011464:Epoprostenol